Stories by California Healthline
Ask Emily
Beware Of Unapproved Stem Cell Treatments
Pricey and unproven therapies that sound too good to be true probably are.
UnitedHealth And University Of California To Forge Unique Alliance
The nation's largest insurer and the state's university health system intend to offer a health plan option to self-funded employers in California and pursue research drawing upon a huge reservoir of patient data.
The Need To Replace EpiPens Regularly Adds To Concerns About Cost
The drug’s manufacturer says it has an expiration date of 12 to 18 months but that includes distribution time, so many customers find they have to buy a new device at least once a year.
The Ads Say ‘Get Your Flu Shot Today,’ But It May Be Wiser To Wait
The flu vaccine is available for longer windows of time. Experts say to weigh convenience and science in deciding when to roll up your sleeve.
A Golden Ticket That Fast-Tracks A Drug Through The FDA
A voucher awarded to companies that find treatments for rare childhood diseases can be sold to the highest bidder — and then used to speed up approvals for much more common drugs.
Picture of Health
Could A Public Option Boost Competition?
California's insurance commissioner has said he supports a public option at the state level to potentially bolster competition and serve as a test for the controversial idea nationwide. According to Covered California data, the state's four biggest insurers control 90 percent of the market.
Audio Report
What’s Behind Rising Insurance Premiums
California Healthline’s Emily Bazar recently joined a panel hosted by San Francisco’s KALW radio to discuss how consumers can minimize the impact of sharply rising Covered California premiums. Listen to her advice below.
Capitol Desk
Specialty Drug Costs Soar 30% For California Pension Fund
Such medications account for more than a quarter of the state agency’s $2.1 billion in pharmacy costs.
Insight
Election Buzz: With Pot On The Ballot, States Weigh How To Police Stoned Drivers
Blood tests for marijuana aren’t an accurate measure of impairment for drivers, and there isn’t an easy roadside sobriety test for pot yet. California and four other states where recreational marijuana is on the ballot might learn from Colorado’s experience.
Ask Emily
Beware Of Unapproved Stem Cell Treatments
Pricey and unproven therapies that sound too good to be true probably are.
Innovations
Twenty dying people, at peace with their mortality, shared their views on life, love and death with a Los Angeles artist for an exhibit at the Museum of Tolerance.
Think Tank
FDA Wants To Tighten The Screws On Stem Cell Clinics
As more and more clinics offer controversial treatments, especially in California, the agency is seeking to clarify its regulatory standards.
Email Sign-up
You can register for free access to the news on this website and have the news emailed to you Monday through Friday.
About California Healthline
California Healthline (CHL) is a free, daily publication featuring health care news, opinion and original reporting, designed to meet the information needs of busy health care professionals, decision makers, media organizations and consumers.
Learn MoreMost Viewed
-
The Ads Say ‘Get Your Flu Shot Today,’ But It May Be Wiser To Wait
-
Remember The ‘Public Option’? Insurance Commissioner Wants To Try It In California
-
Tobacco Tax Ballot Measure Would Fund Health Care For California’s Poor — But How?
Most Shared
- Specialty Drug Costs Soar 30% For California Pension Fund
- Remember The ‘Public Option’? Insurance Commissioner Wants To Try It In California
- It’s In The Water: The Debate Over Fluoridation Lives On In California And Nationwide
- Tobacco Tax Ballot Measure Would Fund Health Care For California’s Poor — But How?
- New California Law Allows Organizations to Buy EpiPens For Emergencies, But Will They?
